Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease

被引:86
|
作者
Karuppuchamy, T. [1 ,2 ]
Behrens, E-H [1 ,2 ]
Gonzalez-Cabrera, P. [3 ]
Sarkisyan, G. [3 ]
Gima, L. [1 ,2 ]
Boyer, J. D. [1 ,2 ]
Bamias, G. [4 ]
Jedlicka, P. [5 ]
Veny, M. [1 ,2 ]
Clark, D. [1 ,2 ]
Peach, R. [6 ]
Scott, F. [6 ]
Rosen, H. [3 ]
Rivera-Nieves, J. [1 ,2 ]
机构
[1] Univ Calif San Diego, Ctr Inflammatory Bowel Dis, Div Gastroenterol, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, San Diego, CA 92161 USA
[3] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA
[4] Laikon Gen Hosp, Acad Dept Gastroenterol, Athens, Greece
[5] Univ Colorado Hlth Sci, Dept Pathol, Aurora, CO USA
[6] Receptos Inc, La Jolla, CA USA
基金
美国国家卫生研究院;
关键词
SPHINGOSINE 1-PHOSPHATE RECEPTOR; GENE-DEFICIENT MICE; CROHNS-DISEASE; MURINE ILEITIS; T-CELLS; MAINTENANCE THERAPY; MULTIPLE-SCLEROSIS; ULCERATIVE-COLITIS; FTY720; MIGRATION;
D O I
10.1038/mi.2016.35
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The sphingosine-1-phosphate receptor-1 (S1P(1)) agonist ozanimod ameliorates ulcerative colitis, yet its mechanism of action is unknown. Here, we examine the cell subsets that express S1P(1) in intestine using S1P(1)-eGFP mice, the regulation of S1P(1) expression in lymphocytes after administration of dextran sulfate sodium (DSS), after colitis induced by transfer of CD4(+) CD45RB(hi) cells, and by crossing a mouse with TNF-driven ileitis with S1P(1)-eGFP mice. We then assayed the expression of enzymes that regulate intestinal S1P levels, and the effect of FTY720 on lymphocyte behavior and S1P(1) expression. We found that not only T and B cells express S1P(1), but also dendritic (DC) and endothelial cells. Furthermore, chronic but not acute inflammatory signals increased S1P(1) expression, while the enzymes that control tissue S1P levels in mice and humans with inflammatory bowel disease (IBD) were uniformly dysregulated, favoring synthesis over degradation. Finally, we observed that FTY720 reduced T-cell velocity and induced S1P(1) degradation and retention of Naive but not effector T cells. Our data demonstrate that chronic inflammation modulates S1P(1) expression and tissue S1P levels and suggests that the anti-inflammatory properties of S1PR agonists might not be solely due to their lymphopenic effects, but also due to potential effects on DC migration and vascular barrier function.
引用
收藏
页码:162 / 171
页数:10
相关论文
共 50 条
  • [31] Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design
    Xiao, Hai-Yun
    Watterson, Scott H.
    Langevine, Charles M.
    Srivastava, Anurag S.
    Ko, Soo S.
    Zhang, Yanlei
    Cherney, Robert J.
    Guo, Wei-Wei
    Gilmore, John L.
    II, James E. Sheppeck
    Wu, Dauh-Rurng
    Li, Peng
    Ramasamy, Duraisamy
    Arunachalam, Piramanayagam
    Mathur, Arvind
    Taylor, Tracy L.
    Shuster, David J.
    McIntyre, Kim W.
    Shen, Ding-Ren
    Yarde, Melissa
    Cvijic, Mary Ellen
    Marino, Anthony M.
    Balimane, Praveen V.
    Yang, Zheng
    Banas, Dana M.
    Cornelius, Georgia
    D'Arienzo, Celia J.
    Warrack, Bethanne M.
    Lehman-McKeeman, Lois
    Salter-Cid, Luisa M.
    Xie, Jenny
    Barrish, Joel C.
    Carter, Percy H.
    Dyckman, Alaric J.
    Dhar, T. G. Murali
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (21) : 9837 - 9854
  • [32] The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis
    Kono, M
    Mi, YD
    Liu, YJ
    Sasaki, T
    Allende, ML
    Wu, YP
    Yamashita, T
    Proia, RL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) : 29367 - 29373
  • [33] A NOVEL MECHANISM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR (S1PR) MODULATORS IN INFLAMMATORY BOWEL DISEASES
    Wang, Jie
    West, Gail A.
    Li, Jiannan
    Dines, Kevin
    Steinberg, Marcos
    Harris, Sarah
    Gordon, Ilyssa
    Mao, Ren
    Lin, Sinan
    Zhao, Shuai
    Dejanovic, Dina
    Fiocchi, Claudio
    Rieder, Florian
    GASTROENTEROLOGY, 2020, 158 (06) : S1040 - S1040
  • [34] A NOVEL MECHANISM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR (S1PR) MODULATORS IN INFLAMMATORY BOWEL DISEASES
    Wang, Jie
    West, Gail A.
    Li, Jiannan
    Dines, Kevin
    Harris, Sarah
    Gordon, Ilyssa O.
    Mao, Ren
    Lin, Sinan
    Zhao, Shuai
    Dejanovic, Dina
    Fiocchi, Claudio
    Rieder, Florian
    GASTROENTEROLOGY, 2021, 160 (06) : S7 - S7
  • [35] Sphingosine-1-phosphate acting via the S1P1 receptor is a downstream signaling pathway in ceramide-induced hyperalgesia
    Doyle, Tim
    Chen, Zhoumou
    Obeid, Lina M.
    Salvemini, Daniela
    NEUROSCIENCE LETTERS, 2011, 499 (01) : 4 - 8
  • [36] Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma
    Rodriguez, A. M.
    Graef, A. J.
    LeVine, D. N.
    Cohen, I. R.
    Modiano, J. F.
    Kim, J. -H.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (04) : 1088 - 1097
  • [37] Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling
    Gatfield, John
    Monnier, Lucile
    Studer, Rolf
    Bolli, Martin H.
    Steiner, Beat
    Nayler, Oliver
    CELLULAR SIGNALLING, 2014, 26 (07) : 1576 - 1588
  • [38] Sphingosine-1-phosphate receptor S1P1 is regulated by direct interactions with P-Rex1, a Rac guanine nucleotide exchange factor
    Alejandro Ledezma-Sanchez, Benjamin
    Garcia-Regalado, Alejandro
    Luisa Guzman-Hernandez, Maria
    Vazquez-Prado, Jose
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (04) : 1647 - 1652
  • [39] Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists
    Hennessy, Edward J.
    Grewal, Gurmit
    Byth, Kate
    Kamhi, Victor M.
    Li, Danyang
    Lyne, Paul
    Oza, Vibha
    Ronco, Lucienne
    Rooney, Michael T.
    Saeh, Jamal C.
    Su, Qibin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (10) : 2041 - 2045
  • [40] The sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis: a unique therapeutic target in inflammatory bowel disease
    Wang, Jie
    Goren, Idan
    Yang, Bo
    Lin, Sinan
    Li, Jiannan
    Elias, Michael
    Fiocchi, Claudio
    Rieder, Florian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 277 - 291